Abstract
Purpose
We aimed to investigate whether 6% HES 130/0.4 was associated with postoperative reduction of estimated glomerular filtration rate (eGFR) in donor patients who underwent nephrectomy for living kidney transplantation.
Methods
This retrospective study included 213 living kidney transplant donors treated at Kyushu University Hospital in Japan from April 2014 to March 2018. Patients who were administered 6% HES 130/0.4 were allocated in the HES group (n = 108), and those who were not were allocated in the control group (n = 105). The postoperative decrements in estimated glomerular filtration rates (eGFRs) from preoperative values were calculated on postoperative days (PODs) 1, 3, and 14. Decline in kidney function (DKF) according to the Kidney Disease: Improving Global Outcomes (KDIGO) classification were analyzed by multivariable-adjusted ordinal logistic regression to estimate odds ratios (ORs) for postoperative DKF.
Results
In HES group, administration amount of HES was median 9.4 [interquartile range: 8.2–14.3] ml/kg. Postoperative decrements in eGFR were similar in the control and HES groups on POD 1 (control group: mean 32.0 vs. HES group: 33.0 mL/min/1.73 m2), same as POD 3 (21.1 vs. 22.4 mL/min/1.73 m2) and POD 14 (26.0 vs. 25.9 mL/min/1.73 m2), even after adjusting for confounding factors. The multivariable-adjusted ORs for postoperative DKF did not significantly increase in the HES group on POD 1 (OR: 0.88), POD 3 (OR: 0.96), and POD 14 (OR: 0.52) compared with the control group.
Conclusion
Six percent HES 130/0.4 is not associated with postoperative renal dysfunction in donor patients undergoing nephrectomy for kidney transplantation.
Similar content being viewed by others
References
Patel MS, Niemann CU, Sally MB, De La Cruz S, Zatarain J, Ewing T, Crutchfield M, Enestvedt CK, Malinoski DJ. The impact of hydroxyethyl starch use in deceased organ donors on the development of delayed graft function in kidney transplant recipients: a propensity-adjusted analysis. Am J Transplant. 2015;15(8):2152–8.
Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, Glass P, Lipman J, Liu B, McArthur C, McGuinness S, Rajbhandari D, Taylor CB, Webb SA, Investigators C, Australian, New Zealand Intensive Care Society Clinical Trials G. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012;367(20): 1901–11.
Hokema F, Ziganshyna S, Bartels M, Pietsch UC, Busch T, Jonas S, Kaisers U. Is perioperative low molecular weight hydroxyethyl starch infusion a risk factor for delayed graft function in renal transplant recipients? Nephrol Dial Transplant. 2011;26(10):3373–8.
Blasco V, Leone M, Antonini F, Geissler A, Albanese J, Martin C. Comparison of the novel hydroxyethylstarch 130/0.4 and hydroxyethylstarch 200/0.6 in brain-dead donor resuscitation on renal function after transplantation. Br J Anaesth. 2008;100(4):504–8.
Zhou ZB, Shao XX, Yang XY, Zhang T, Xian DF, Huang CY, Yang L, Huang WQ. Influence of hydroxyethyl starch on renal function after orthotopic liver transplantation. Transplant Proc. 2015;47(6):1616–9.
Miyao H, Kotake Y. Renal morbidity of 6% hydroxyethyl starch 130/0.4 in 9000 propensity score matched pairs of surgical patients. Anesth Analg. 2020;130(6):1618–27.
Pagel JI, Rehm M, Kammerer T, Hulde N, Speck E, Briegel J, Reinholz F, Crispin A, Hofmann-Kiefer KF. Hydroxyethyl starch 130/0.4 and its impact on perioperative outcome: a propensity score matched controlled observation study. Anesth Analg. 2018;126(6):1949–56.
Kasiske BL, Anderson-Haag T, Israni AK, Kalil RS, Kimmel PL, Kraus ES, Kumar R, Posselt AA, Pesavento TE, Rabb H, Steffes MW, Snyder JJ, Weir MR. A prospective controlled study of living kidney donors: three-year follow-up. Am J Kidney Dis. 2015;66(1):114–24.
Benoit T, Game X, Roumiguie M, Sallusto F, Doumerc N, Beauval JB, Rischmann P, Kamar N, Soulie M, Malavaud B. Predictive model of 1-year postoperative renal function after living donor nephrectomy. Int Urol Nephrol. 2017;49(5):793–801.
Toyoda M, Yamanaga S, Kawabata C, Hidaka Y, Inadome A, Arakane F, Uekihara S, Seishi I. Long-term safety of living kidney donors aged 60 and older. Transplant Proc. 2014;46(2):318–20.
Yakoubi R, Autorino R, Kassab A, Long JA, Haber GP, Kaouk JH. Does preserved kidney volume predict 1 year donor renal function after laparoscopic living donor nephrectomy? Int J Urol. 2013;20(9):931–4.
Fahmy LM, Massie AB, Muzaale AD, Bagnasco SM, Orandi BJ, Alejo JL, Boyarsky BJ, Anjum SK, Montgomery RA, Dagher NN, Segev DL. Long-term renal function in living kidney donors who had histological abnormalities at donation. Transplantation. 2016;100(6):1294–8.
Vats HS, Rayhill SC, Thomas CP. Early postnephrectomy donor renal function: laparoscopic versus open procedure. Transplantation. 2005;79(5):609–12.
Mertenszur Borg IR, Kok NF, Lambrou G, Jonsson D, Alwayn IP, Tran KT, Weimar W, Ijzermans JN, Gommers D. Beneficial effects of a new fluid regime on kidney function of donor and recipient during laparoscopic v open donor nephrectomy. J Endourol. 2007;21(12):1509–15.
Mertenszur Borg IR, Di Biase M, Verbrugge S, Ijzermans JN, Gommers D. Comparison of three perioperative fluid regimes for laparoscopic donor nephrectomy: a prospective randomized dose-finding study. Surg Endosc. 2008;22(1):146–50.
Horio M, Imai E, Yasuda Y, Watanabe T, Matsuo S. Modification of the CKD epidemiology collaboration (CKD-EPI) equation for Japanese: accuracy and use for population estimates. Am J Kidney Dis. 2010;56(1):32–8.
Machado MN, Nakazone MA, Maia LN. Acute kidney injury based on KDIGO (Kidney Disease Improving Global Outcomes) criteria in patients with elevated baseline serum creatinine undergoing cardiac surgery. Rev Bras Cir Cardiovasc. 2014;29(3):299–307.
Cleveland WS, Devlin SJ. Locally weighted regression: an approach to regression analysis by local fitting. J Am Stat Assoc. 1988;83(403):596–610.
Zhang Y, Yu Y, Jia J, Yu W, Xu R, Geng L, Wei Y. Administration of HES in elderly patients undergoing hip arthroplasty under spinal anesthesia is not associated with an increase in renal injury. BMC Anesthesiol. 2017;17(1):29.
Mathis MR, Naik BI, Freundlich RE, Shanks AM, Heung M, Kim M, Burns ML, Colquhoun DA, Rangrass G, Janda A, Engoren MC, Saager L, Tremper KK, Kheterpal S, Aziz MF, Coffman T, Durieux ME, Levy WJ, Schonberger RB, Soto R, Wilczak J, Berman MF, Berris J, Biggs DA, Coles P, Craft RM, Cummings KC, Ellis TA, 2nd, Fleishut PM, Helsten DL, Jameson LC, van Klei WA, Kooij F, LaGorio J, Lins S, Miller SA, Molina S, Nair B, Paganelli WC, Peterson W, Tom S, Wanderer JP, Wedeven C, Multicenter Perioperative Outcomes Group I. Preoperative Risk and the Association between Hypotension and Postoperative Acute Kidney Injury. Anesthesiology. 2020;132(3): 461–75.
Persson MO, Persson NH, Kallen R, Ekberg H, Hermeren G. Kidneys from marginal donors: views of patients on informed consent. Nephrol Dial Transplant. 2002;17(8):1497–502.
Saito T, Uchida K, Ishida H, Tanabe K, Nitta K. Changes in glomerular filtration rate after donation in living kidney donors: a single-center cohort study. Int Urol Nephrol. 2015;47(2):397–403.
Fehrman-Ekholm I, Kvarnstrom N, Softeland JM, Lennerling A, Rizell M, Oden A, Simonsson T. Post-nephrectomy development of renal function in living kidney donors: a cross-sectional retrospective study. Nephrol Dial Transplant. 2011;26(7):2377–81.
Godinho I, Guerra J, Melo MJ, Neves M, Goncalves J, Santana MA, Gomes da Costa A. Living-donor kidney transplantation: donor-recipient function correlation. Transplant Proc. 2018;50(3):719–22.
Westphal M, James MF, Kozek-Langenecker S, Stocker R, Guidet B, Van Aken H. Hydroxyethyl starches: different products–different effects. Anesthesiology. 2009;111(1):187–202.
Jungheinrich C, Neff TA. Pharmacokinetics of hydroxyethyl starch. Clin Pharmacokinet. 2005;44(7):681–99.
Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A, Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6): 982–92.
Funding
Supported by departmental funding only.
Author information
Authors and Affiliations
Contributions
KS, YO and AT design the study, collected data, evaluated the data and drafted the manuscript. KU performed the statistical analyses and revised the manuscript. MW designed the study, and evaluated the data. KY evaluated the data and revised the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
IRB
Faculty of Medical sciences, Kyushu University Institutional Review Board Clinical Research number #30–53.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
About this article
Cite this article
Shirozu, K., Umehara, K., Watanabe, M. et al. Evaluation of postoperative kidney function after administration of 6% hydroxyethyl starch during living-donor nephrectomy for transplantation. J Anesth 35, 59–67 (2021). https://doi.org/10.1007/s00540-020-02862-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00540-020-02862-z